Oaktree Acquisition Corp III Unit (OACCU)
Oaktree Acquisition Corp. III Unit is a listed debt/equity composite unit on NASDAQ associated with Oaktree Acquisition Corp. III Life Sciences. The underlying issuer has no significant operating business and was formed to pursue a business combination through a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar transaction. Its initial focus is on companies in biopharmaceuticals, medical devices, diagnostics, and specialized healthcare services, with an emphasis on opportunities in North America and Europe. The issuer was incorporated in 2024 and is based in Los Angeles, California. As a unit security, the instrument reflects the listed composite structure rather than an operating company’s regular commercial activities.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-OACC.U
|
$9.73
|
-10.6% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 13, 2026
|
39.0x
|
264.8 M
|
262.4 M
|
0.0%
|
75.1%
|
0.7
|
-6.7%
|